famotidine has been researched along with Lymphopenia in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Lymphopenia: Reduction in the number of lymphocytes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our results indicate that famotidine could result in a significant reduction in radiation-induced lymphocytopenia and may consequently increase radiotherapy efficacy as well as survival times." | 9.19 | Reduction in radiation-induced lymphocytopenia by famotidine in patients undergoing radiotherapy for prostate cancer. ( Aghamiri, SM; Heidari, AH; Mofid, B; Mozdarani, H; Razzaghdoust, A, 2014) |
| "Our results indicate that famotidine could result in a significant reduction in radiation-induced lymphocytopenia and may consequently increase radiotherapy efficacy as well as survival times." | 5.19 | Reduction in radiation-induced lymphocytopenia by famotidine in patients undergoing radiotherapy for prostate cancer. ( Aghamiri, SM; Heidari, AH; Mofid, B; Mozdarani, H; Razzaghdoust, A, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Razzaghdoust, A | 1 |
| Mozdarani, H | 1 |
| Mofid, B | 1 |
| Aghamiri, SM | 1 |
| Heidari, AH | 1 |
1 trial available for famotidine and Lymphopenia
| Article | Year |
|---|---|
Reduction in radiation-induced lymphocytopenia by famotidine in patients undergoing radiotherapy for prostate cancer.
Topics: Administration, Oral; Aged; Famotidine; Humans; Lymphopenia; Male; Middle Aged; Prospective Studies; | 2014 |